NOT-CA-23-003: Notice of Correction of Key Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

Notice of Correction of Key Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

Notice Number:

NOT-CA-23-003

Key Dates

Release Date:

October 19, 2022

Related Announcements

RFA-CA-22-042 - Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice corrects the Table for Application Due Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional).

The following section of RFA-CA-22-042 has been corrected:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
January 23, 2023	Not Applicable	Not Applicable	April 2023	August 2023	October 2023
October 16, 2023	October 16, 2023	Not Applicable	February 2024	May 2024	July 2024

Expiration Date: October 17, 2023

Corrected to read (in bold italics):

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
January 23, 2023	Not Applicable	Not Applicable	April 2023	August 2023	October 2023
*October 15, 2023*	*October 15, 2023*	Not Applicable	February 2024	May 2024	July 2024

Expiration Date: October 16, 2023

All other aspects of RFA-CA-22-042 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Rachel Grana Mayne, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-5899
Email: [email protected]

Kevin Walton, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5980
E-mail: [email protected]

Evan Sullivan Herrmann, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-443-1428
E-mail: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 240-276-5699
Email: [email protected]

Amy Connolly
National Institute on Drug Abuse (NIDA)
Phone: (301) 827-4457
E-mail: [email protected]